Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Irene Turturici"'
Autor:
Michela Buglione, Daniela Alterio, Marta Maddalo, Diana Greco, Marianna Alessandra Gerardi, Davide Tomasini, Ludovica Pegurri, Matteo Augugliaro, Giulia Marvaso, Irene Turturici, Andrea Guerini, Mohssen Ansarin, Luigi Spiazzi, Loredana Costa, Maria Cossu Rocca, Stefano Maria Magrini, Barbara Alicja Jereczek-Fossa
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-13 (2021)
Abstract Background Radio-chemotherapy with CDDP is the standard for H&N squamous cell cancer. CDDP 100 mg/m2/q3 is the standard; alternative schedules are used to reduce toxicity, mostly 40 mg/m2/q1. Methods Patients were treated from 1/2010 to 1/20
Externí odkaz:
https://doaj.org/article/d5b7cd3b4fb74131a7d1e785859eafe9
Autor:
Valentina Lancellotta, Giuseppe Fanetti, Fabio Monari, Monica Mangoni, Renzo Mazzarotto, Luca Tagliaferri, Carlo Gobitti, Elisa Lodi Rizzini, Sara Talomo, Irene Turturici, Fabiola Paiar, Renzo Corvò, Barbara Alicja Jereczek-Fossa, Vittorio Donato, Federica Vianello
Publikováno v:
La radiologia medica. 127:681-689
The aim of this systematic review was to examine efficacy of stereotactic radiotherapy (SRT) in patients with oligometastatic thyroid cancer.A systematic search was conducted by means of PubMed, Scopus, and Cochrane library.gov was searched for ongoi
Autor:
Mariateresa Casarotto, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D'Angelo, Carlo Furlan, Anna Menegaldo, Lorena Baboci, Barbara Montico, Irene Turturici, Riccardo Dolcetti, Salvatore Romeo, Vittorio Baggio, Stefania Corrado, Gianluca Businello, Maria Guido, Alessandro Weisz, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Luca Sigalotti, Emanuela Vaccher, Paolo Boscolo-Rizzo, Jerry Polesel, Giuseppe Fanetti, Elisabetta Fratta
Publikováno v:
Cancer Research. 83:1005-1005
Background: Currently, human papillomavirus (HPV) positivity represents a strong prognostic factor for both reduced risk of relapse and improved survival in patients with oropharyngeal squamous cell carcinoma (OPSCC). However, a subset of HPV-positiv
Autor:
Stefania Volpe, Aurora Gaeta, Francesca Colombo, Mattia Zaffaroni, Federico Mastroleo, Maria Giulia Vincini, Matteo Pepa, Lars Johannes Isaksson, Irene Turturici, Giulia Marvaso, Annamaria Ferrari, Giulio Cammarata, Riccardo Santamaria, Jessica Franzetti, Sara Raimondi, Francesca Botta, Mohssen Ansarin, Sara Gandini, Marta Cremonesi, Roberto Orecchia, Daniela Alterio, Barbara Alicja Jereczek-Fossa
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2022
Aims: To assess whether CT-based radiomics and blood-derived biomarkers could improve the prediction of overall survival (OS) and locoregional progression-free survival (LRPFS) in patients with oropharyngeal cancer (OPC) treated with curative-intent
Autor:
Daniela Alterio, Rita De Berardinis, Matteo Augugliaro, Pasqualina D’Urso, Stefania Volpe, Fausto Maffini, Roberto Bruschini, Giulia Marvaso, Stefano Riccio, Marta Tagliabue, Irene Turturici, Alessia Farneti, Luca Calabrese, Anna Starzyńska, Annamaria Ferrari, Mattia Zaffaroni, Barbara Alicja Jereczek-Fossa, Giuseppe Sanguineti, Mohssen Ansarin
Publikováno v:
Br J Radiol
Objective: The last edition of the American Joint Committee on Cancer (AJCC eighth) has introduced the depth of infiltration (DOI) as a new prognostic parameter in oral cavity squamous cell carcinomas (OCSCCs). The aim of this study is to analyze the
Autor:
Mariateresa Casarotto, Valentina Lupato, Giorgio Giurato, Roberto Guerrieri, Sandro Sulfaro, Annamaria Salvati, Elisa D’Angelo, Carlo Furlan, Anna Menegaldo, Lorena Baboci, Barbara Montico, Irene Turturici, Riccardo Dolcetti, Salvatore Romeo, Vittorio Baggio, Stefania Corrado, Gianluca Businello, Maria Guido, Alessandro Weisz, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Luca Sigalotti, Emanuela Vaccher, Paolo Boscolo-Rizzo, Polesel Jerry, Giuseppe Fanetti, Elisabetta Fratta
Background and purpose Currently, human papillomavirus (HPV) positivity represents a strong prognostic factor for both reduced risk of relapse and improved survival in patients with oropharyngeal squamous cell carcinoma (OPSCC). However, a subset of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::120b4b67ba7cda312909e192fb376212
https://hdl.handle.net/11368/3036391
https://hdl.handle.net/11368/3036391
Autor:
Rita De Berardinis, Stefano Riccio, Annamaria Ferrari, Giuseppe Sanguineti, Daniela Alterio, Pasqualina D’Urso, Stefania Volpe, Matteo Augugliaro, Marta Tagliabue, Luca Calabrese, Alessia Farneti, Irene Turturici, Roberto Bruschini, Sara Gandini, Barbara Alicja Jereczek-Fossa, Mohssen Ansarin, Fausto Maffini, Anna Starzyńska
Publikováno v:
Cancers
Volume 13
Issue 19
Cancers, Vol 13, Iss 4851, p 4851 (2021)
Volume 13
Issue 19
Cancers, Vol 13, Iss 4851, p 4851 (2021)
Background: This study investigated the role of depth of infiltration (DOI) as an independent prognosticator in early stage (T1-T2N0M0) oral cavity tumors and to evaluate the need of postoperative radiotherapy in the case of patients upstaged to pT3
Autor:
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, Emanuela Vaccher, Irene Turturici, Valentina Lupato, Fabio Biagio La Torre, Jerry Polesel, Elisabetta Fratta, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Michele Spina, Salvatore Alfieri
Publikováno v:
Critical Reviews in Oncology/Hematology. 175:103707
Amongst the chief targets of immune-checkpoint inhibitors (ICIs), namely the Programmed cell death protein 1 (PD-1)/PD-Ligands (Ls) axis, most research has focused on PD-L1, while to date PD-L2 is still under-investigated. However, emerging data supp
Autor:
Marta Maddalo, Giulia Marvaso, Davide Tomasini, Luigi Spiazzi, Andrea Emanuele Guerini, Irene Turturici, Marianna Alessandra Gerardi, D. Alterio, Michela Buglione, Maria Cossu Rocca, Matteo Augugliaro, L. Costa, Mohssen Ansarin, Diana Greco, L. Pegurri, Stefano Maria Magrini, Barbara Alicja Jereczek-Fossa
Background Radio-chemotherapy with CDDP is the standard for H&N squamous cell cancer. CDDP 100mg/m2/q3 is the standard; alternative schedules are used to reduce toxicity, mostly 40mg/m2/q1. Methods Patients were treated from 1/2010 to 1/2017 in two R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc3b2f49d3a0f6208b2f1c06d68b3a2d
https://doi.org/10.21203/rs.3.rs-403139/v1
https://doi.org/10.21203/rs.3.rs-403139/v1
Autor:
Barbara Alicja Jereczek-Fossa, Sara Gandini, Rosalinda Ricotti, Irene Turturici, A.M. Camarda, Barbara Vischioni, S. Ronchi, Giuseppe Magro, Marta Tagliabue, Daniela Alterio, Piero Fossati, E. La Rocca, Ester Orlandi, Roberto Orecchia, Maria Bonora, Viviana Vitolo, Giulia Marvaso, Elena Verri, Stefania Volpe, Stefania Comi, Edoardo Mastella, Pierfrancesco Franco, E. D’Ippolito, Marco Krengli
Publikováno v:
Radiotherapy and Oncology. 161:S827-S828